Terry Kenakin’s latest lecture in Terry’s Corner  delivers exactly what your discovery teams need now Redefine your playbook:  Why Serafini believes that pain research needs to start from clinical phenotype GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need Don’t Fall Behind—Access the Edge You Need 👉 Ready to sharpen your discovery decisions?

You don’t need more data—you need a way to translate snapshots into predictions. The lesson: models don’t just need data. They need the right data . , pharmacologists refining fundamentals, scientists challenging legacy assumptions, and leaders who need

"When you talk to patients that have an unmet need, you learn things that no one is thinking about in how personal pain can lead to professional purpose — and why the next generation of pain researchers needs

Don't let misconceptions about receptor binding kinetics slow your progress—gain the clarity you need Our weekly curated news and expert frameworks provide the actionable intelligence you need to make sense GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need Don’t Fall Behind—Access the Edge You Need 👉 Become a Premium Member Today ➤ Already a Premium Member Gain the insights, tools, and connections you need to excel in your field and make your mark.

Takeaway We don’t need better in vitro data — we need better models of reality. Dr.

GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need GPCR the best for the sake of promoting more educational opportunities that are sorely needed in the

If you need to brief leadership, plan experiments, or time a move in the market or your career, Premium GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need Kenakin is a masterful teacher and communicator." — DrGPCR University Attendee Everything you need to

It’s a response to unmet scientific needs: Replace microscopy-heavy workflows with no-wash, live-cell Podcast, the Revvity team built pHSense™ from the ground up by listening to what GPCR scientists actually need—and GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Fluorescent ligands based on small molecules bind to the functional sites of receptors in live cells, no need No need for fixation and permeabilization This step can modify receptor conformation and affect downstream Compatibility with live cells No need for fixation of permeabilization.

Power analysis tells you exactly how many replicates you need for 95% confidence. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need

re stuck trying to figure out why your lead compound looks promising in vitro but flops in vivo, you need

Fluorescence Polarization (FP) is especially useful since it allows real time detection and there is no need This means no washing steps are needed to reduce background signal. Figure 1. Unlike other techniques (FRET-based), only one fluorophore is needed.

contradictory This lesson isn’t just academic—it’s practical knowledge every early-stage scientist needs

A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization Tool Designed for Real Research Needs s of GPCR assay innovation , pHSense™  was developed to overcome

week: high-impact insight into GPCR allostery, crafted for pharmacologists and biotech scientists who need Why you need to be there: Learn how kinetic nuance shapes ligand design.   GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need

The excitement I felt when I first attended back in Boston is the same one I feel now that I am the organizer historically excluded demographics are finally included, this represents a building block to reinforce the need Mariachi song: I typically do not sing to these since they are dear to Mexican childhood memories, and I feel

First responders describe revivals that don’t feel like revivals, as if the body is still trapped in those pathways, her research gives scientists, first responders, and policymakers the knowledge they need

technical overview, this is a story of curiosity, persistence, and using science to meet unmet clinical needs publish or patent; it was to bring a novel, safer class of pain therapeutics to patients — an urgent need Whether it's chronic pain, addiction, or another unmet need, keeping the real-world impact in focus can

Traditional roles rarely gave me the freedom to implement these changes at the scale needed. conversations keep me on the front lines, sharpening my understanding of the common bottlenecks and evolving needs

Other times, you’ll need to sprint. Knowing the difference is survival.

, and system sensitivity to surface mechanism—before you lock in a screen that hides the signal you need translational pharmacologists, biotech discovery teams, platform company leaders, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need

incorporating kinetic modeling early in your pipeline, ensuring your candidates have the persistence needed GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need

Building for the Future The Sakmar lab built a system to meet that need: Dual-epitope tagged constructs

. 👉 Email us to chat, collaborate and tell us what you need ➤ Terry’s Corner—Basic Pharmacokinetics GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

What is needed is the biochemical resolution to tell them apart. a high-value pharmacological target for which specific assays to detect these effects reliably are needed in Practice: Reading the Full Signaling Fingerprint Using complementary assay formats provides the needed

GPCR scientists, translational pharmacologists, biotech drug discovery teams, and decision-makers who need Don’t Fall Behind—Access the Edge You Need 👉 Access all the news and upcoming events ➤ 👉 Already a To succeed, you need to move beyond standard approaches and adopt the frameworks that are driving real

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need ’s breakthroughs—and avoid delays others won’t see coming. 👉 Don’t Fall Behind—Access the Edge You Need

classic models of Schild and Gaddum  continue to inform modern analysis, while also highlighting the need topics Who it’s for:  drug discovery teams, pharmacologists refining their toolkit, and scientists who need

This emphasis may have caused other signaling pathways to be overlooked due to a need for adequate assay aberrant ERK activity can lead to uncontrolled cell proliferation and survival​, highlighting the pressing need This further underscores the need for advanced assay technologies and a deep understanding of cellular

It’s a system-aware resource built for researchers who need clarity fast—reinforcing system-level GPCR Don’t Fall Behind—Access the Edge You Need Already a Premium Member?